Literature DB >> 27106252

Serum Uric Acid and Risk for Acute Kidney Injury Following Contrast.

Mehmet Kanbay1, Yalcin Solak2, Baris Afsar3, Ionut Nistor4,5, Gamze Aslan6, Ozlem Hilal Çağlayan1, Asli Aykanat1, Mihaela-Dora Donciu4, Miguel A Lanaspa7, Ahsan A Ejaz8, Richard J Johnson7, Adrian Covic4.   

Abstract

Contrast-induced acute kidney injury (CI-AKI) is a common cause of hospital-acquired acute kidney injury (AKI). We evaluated the evidence that uric acid (UA) plays a pathogenic role in CI-AKI. Ten studies were eligible for inclusion for meta-analysis. Hyperuricemia predicted risk for cases with AKI in prospective cohort studies. Higher levels of serum UA (SUA), as defined by the authors, were associated with a 2-fold increased risk to develop AKI (pooled odds ratio 2.03; 95% confidence interval [CI] 1.48-2.78). Significant heterogeneity was found in cohort studies ( P = .001, I2 = 85.7%). In 2 clinical trials, lowering of SUA with saline hydration was significantly associated with reduced risk for AKI compared with saline hydration alone or saline hydration with N-acetyl cysteine. An analysis of 2 randomized controlled trials found that allopurinol with saline hydration had a significant protective effect on renal function (assessed by serum creatinine values) compared with hydration alone (mean difference: -0.52 mg/dL; 95% CI: -0.81 to -0.22). Hyperuricemia independently predicts CI-AKI. Two clinical trials suggest lowering SUA may prevent CI-AKI. The mechanism by which UA induces CI-AKI is likely related to acute uricosuria.

Entities:  

Keywords:  acute kidney injury; allopurinol; contrast nephropathy; uric acid

Mesh:

Substances:

Year:  2016        PMID: 27106252     DOI: 10.1177/0003319716644395

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  20 in total

1.  Serum osmolarity as a potential predictor for contrast-induced nephropathy following elective coronary angiography.

Authors:  Mehmet Kanbay; Dimitrie Siriopol; Elif Ozdogan; Baris Afsar; Lale A Ertuglu; Mihaela Grigore; Alan A Sag; Masanari Kuwabara; Miguel A Lanaspa; Alberto Ortiz; Richard J Johnson; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2020-02-01       Impact factor: 2.370

Review 2.  Dietary and commercialized fructose: Sweet or sour?

Authors:  Aslihan Yerlikaya; Tuncay Dagel; Christopher King; Masanari Kuwabara; Miguel A Lanaspa; Ana Andres-Hernando; Adrian Covic; Jacek Manitius; Alan A Sag; Mehmet Kanbay
Journal:  Int Urol Nephrol       Date:  2017-02-16       Impact factor: 2.370

Review 3.  Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation.

Authors:  Richard J Johnson; George L Bakris; Claudio Borghi; Michel B Chonchol; David Feldman; Miguel A Lanaspa; Tony R Merriman; Orson W Moe; David B Mount; Laura Gabriella Sanchez Lozada; Eli Stahl; Daniel E Weiner; Glenn M Chertow
Journal:  Am J Kidney Dis       Date:  2018-02-27       Impact factor: 8.860

Review 4.  Roles of hyperuricemia in metabolic syndrome and cardiac-kidney-vascular system diseases.

Authors:  Hongsha Wang; Haifeng Zhang; Lin Sun; Weiying Guo
Journal:  Am J Transl Res       Date:  2018-09-15       Impact factor: 4.060

Review 5.  The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD.

Authors:  Yuka Sato; Daniel I Feig; Austin G Stack; Duk-Hee Kang; Miguel A Lanaspa; A Ahsan Ejaz; L Gabriela Sánchez-Lozada; Masanari Kuwabara; Claudio Borghi; Richard J Johnson
Journal:  Nat Rev Nephrol       Date:  2019-07-11       Impact factor: 28.314

6.  Weak Association Between Genetic Markers of Hyperuricemia and Cardiorenal Outcomes: Insights From the STANISLAS Study Cohort With a 20-Year Follow-Up.

Authors:  Mehmet Kanbay; Constance Xhaard; Edith Le Floch; Claire Dandine-Roulland; Nicolas Girerd; João Pedro Ferreira; Jean-Marc Boivin; Sandra Wagner; Delphine Bacq-Daian; Jean-François Deleuze; Faiez Zannad; Patrick Rossignol
Journal:  J Am Heart Assoc       Date:  2022-04-26       Impact factor: 6.106

Review 7.  Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: A review.

Authors:  Usama A A Sharaf El Din; Mona M Salem; Dina O Abdulazim
Journal:  J Adv Res       Date:  2016-12-03       Impact factor: 10.479

Review 8.  Serum uric acid and acute kidney injury: A mini review.

Authors:  Kai Hahn; Mehmet Kanbay; Miguel A Lanaspa; Richard J Johnson; A Ahsan Ejaz
Journal:  J Adv Res       Date:  2016-09-24       Impact factor: 10.479

Review 9.  Post-contrast acute kidney injury - Part 1: Definition, clinical features, incidence, role of contrast medium and risk factors : Recommendations for updated ESUR Contrast Medium Safety Committee guidelines.

Authors:  Aart J van der Molen; Peter Reimer; Ilona A Dekkers; Georg Bongartz; Marie-France Bellin; Michele Bertolotto; Olivier Clement; Gertraud Heinz-Peer; Fulvio Stacul; Judith A W Webb; Henrik S Thomsen
Journal:  Eur Radiol       Date:  2018-02-09       Impact factor: 5.315

Review 10.  Hyperuricemia in Kidney Disease: A Major Risk Factor for Cardiovascular Events, Vascular Calcification, and Renal Damage.

Authors:  Abutaleb Ahsan Ejaz; Takahiko Nakagawa; Mehmet Kanbay; Masanari Kuwabara; Ada Kumar; Fernando E Garcia Arroyo; Carlos Roncal-Jimenez; Fumihiko Sasai; Duk-Hee Kang; Thomas Jensen; Ana Andres Hernando; Bernardo Rodriguez-Iturbe; Gabriela Garcia; Dean R Tolan; Laura G Sanchez-Lozada; Miguel A Lanaspa; Richard J Johnson
Journal:  Semin Nephrol       Date:  2020-11       Impact factor: 5.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.